Clinical pathway management in the patients undergoing leiomyoma of uterus
10.3760/cma.j.issn.1673-4203.2009.08.014
- VernacularTitle:子宫平滑肌瘤手术患者实施临床路径管理的探讨
- Author:
Fang XU
;
Mei CUI
;
Zengping HAO
- Publication Type:Journal Article
- Keywords:
leiomyoma of uterus;
clinical pathway;
hospital quality management
- From:
International Journal of Surgery
2009;36(8):536-538
- CountryChina
- Language:Chinese
-
Abstract:
Objective Investigate the effect of applying clinical pathway on the patients undergoing leiomyoma of uterus. Methods As an experimental group of patients, 50 cases of uterine leiomyoma are treated with clinical pathway. By contrast, another 100 cases are treated with the traditional medical care as control group. Results Waiting time for surgery and hospital stay of the experimental group are less than the control group; and the average hospitalization cost of experimental group is lower than the control group (P< 0.01). Conclusions Application of clinical pathway management will regulate the activities of medical treatment, ensure the quality of health care, improve the feeling of patients, increase efficiency of hospital services, reduce the financial burden of patients, increase the hospital social benefits.